Li J H, Yasay G D, Kau S T, Ohnmacht C J, Trainor D A, Bonev A D, Heppner T J, Nelson M T
Department of Pharmacology, Zeneca Pharmaceuticals Group, Zeneca Inc., Wilmington, Delaware, USA.
Arzneimittelforschung. 1996 May;46(5):525-30.
The potassium (K+) channel opening activity of ZM244085 (9-(3-cyanophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H,5H)-acridined ione, CAS 149398-59-4), a novel dihydropyridine (DHP), was ascertained. In a set of functional assays, its mechanoinhibitory effect on myogenic activity of guinea pig bladder detrusor muscles, either mildly or highly depolarized with 15 or 80 mmol/l KCl, was measured. ZM244085 had negligible effect on the tone of the detrusor contracted with 80 mmol/l KCl but reduced the myogenic activity induced with 15 mmol/l KCl (IC50=4.2 +/- 0.4 mumol/l). Glibenclamide, an ATP-sensitive K+ (KATP) channel blocker, competitively antagonized this action of ZM244085 with a pA2 value of 7.6. This functional profile of ZM244085 is similar to that of the prototypic K+ channel opener cromakalim but stands in contrast to that of typical DHP Ca2+ channel blockers such as nifedipine and nimodipine. The membrane potential of the guinea pig detrusor, recorded with intracellular microelectrodes, was hyperpolarized 6.8 +/- 3.1 mV by ZM244085 (10 mumol/l). This hyperpolarization was completely blocked by glibenclamide but not affected by apamin (10 mumol/l), a toxin blocking specifically small conductance and Ca2+ dependent K+ (SKCa) channels. ZM244085 (10 mumol/l) increased the whole cell KATP current in isolated guinea pig detrusor cells by 8.8 +/- 2.5 pA, but failed to activate large conductance and Ca2+ dependent K+ (BKCa) channels in excised inside-out membrane patches from those cells. The results from these studies showed that ZM244085 is a K+ channel opener which activates predominantly KATP channels in vitro to relax bladder detrusors.
一种新型二氢吡啶(DHP)ZM244085(9 -(3 - 氰基苯基)- 3,4,6,7,9,10 - 六氢 - 1,8 -(2H,5H)- 吖啶二酮,CAS 149398 - 59 - 4)的钾(K +)通道开放活性已得到确证。在一组功能测定中,测量了其对豚鼠膀胱逼尿肌肌源性活性的机械抑制作用,该逼尿肌分别用15或80 mmol/L KCl轻度或高度去极化。ZM244085对用80 mmol/L KCl收缩的逼尿肌张力影响可忽略不计,但降低了用15 mmol/L KCl诱导的肌源性活性(IC50 = 4.2±0.4 μmol/L)。格列本脲,一种ATP敏感性钾(KATP)通道阻滞剂,以7.6的pA2值竞争性拮抗ZM244085的这一作用。ZM244085的这种功能特征与原型钾通道开放剂克罗卡林相似,但与典型的二氢吡啶类钙通道阻滞剂如硝苯地平和尼莫地平相反。用细胞内微电极记录的豚鼠逼尿肌膜电位被ZM244085(10 μmol/L)超极化6.8±3.1 mV。这种超极化被格列本脲完全阻断,但不受阿帕明(10 μmol/L)影响,阿帕明是一种特异性阻断小电导和钙依赖性钾(SKCa)通道的毒素。ZM244085(10 μmol/L)使分离的豚鼠逼尿肌细胞中的全细胞KATP电流增加8.8±2.5 pA,但未能激活来自这些细胞的内向外膜片上的大电导和钙依赖性钾(BKCa)通道。这些研究结果表明,ZM244085是一种钾通道开放剂,在体外主要激活KATP通道以松弛膀胱逼尿肌。